Large-scale, Multinational CF Study Enrolls First Patient

A collaboration among researchers in nine countries across Europe, North America, and Australia, ACTIVATE-CF investigates whether regular exercise improves outcomes such as pulmonary function or exercise capacity for individuals with Cystic Fibrosis (CF). CF is a genetic disorder affecting approximately 1 in 2,500 people worldwide. Although there is no cure, affected individuals live longer than ever before. The EBPI team, led by PD Dr. med Susi Kriemler, established and now maintains the 300-patient database for the study, which seeks to slow the course of lung deterioration and maintain physical and mental health among people diagnosed with CF.

Walter Schmid

News